More of the Same: ICER’s latest salvo on rare diseases

More of the Same: ICER’s latest salvo on rare diseases

Earlier this month, ICER released a white paper titled “The Next Generation of Rare Disease Drug Policy: Ensuring Both Innovation and Affordability.” If you have been monitoring ICER’s work over the years, the paper likely matches your expectations. Ostensibly, the...
Event: Health Plan Heroes Awards Program and Roundtable

Event: Health Plan Heroes Awards Program and Roundtable

Patients Rising’s first annual Health Plan Heroes event will honor companies that have adopted innovative benefit design for their employees. In addition, a panel of experts will have a roundtable discussion on ways for employers to enhance patient access to...
Giving Patients a Window into Healthcare Costs

Giving Patients a Window into Healthcare Costs

For years, policymakers across the political spectrum have sought to make the U.S. healthcare system more transparent. Unfortunately, the status quo too often incentivizes policies and practices that seem designed to keep patients in the dark about the real cost of...